Smith & Nephew (SNN) Return on Invested Capital (2014 - 2024)
Smith & Nephew (SNN) posted quarterly Return on Invested Capital of 0.01% for Q4 2024, up 1.0% year-on-year from 0.01% in Q1 2024, and up 353.09% on a QoQ basis from 0.0% in Q4 2023.
Smith & Nephew (SNN) Return on Invested Capital (2014 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Return on Invested Capital for 11 consecutive years, with 0.01% the latest figure, recorded in Q4 2024.
- Quarterly Return on Invested Capital rose 1.0% year-over-year to 0.01% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.13%, up 1.0% from the prior year.
- Return on Invested Capital rose to 0.01% in Q4 2024 per SNN's latest filing, from 0.0% in the prior quarter.
- Over the last five years, Return on Invested Capital for SNN reached as high as 0.01% in Q4 2020 and fell as low as 0.0% in Q4 2023.
- A 5-year average of 0.0% and a median of 0.0% in 2021 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2020 — Return on Invested Capital changed 0 bps — and 2024, when it advanced 1 bps.
- Year by year, Return on Invested Capital stood at 0.01% in 2020, then slumped by 55 bps to 0.0% in 2021, then sank by 39 bps to 0.0% in 2022, then sank by 35 bps to 0.0% in 2023, then jumped by 353 bps to 0.01% in 2024.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.01%, 0.0%, and 0.0% for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.01% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.01% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.00% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.00% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 0.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.01% |
| Dec 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Dec 31, 2020 | 0.01% |
| Dec 31, 2019 | 0.01% |
| Dec 31, 2018 | 0.01% |
| Dec 31, 2017 | 0.01% |
| Dec 31, 2016 | 0.02% |
| Dec 31, 2015 | 0.02% |
| Dec 31, 2014 | 0.03% |
| Sep 30, 2014 | 0.03% |
| Mar 31, 2014 | 0.04% |